337 related articles for article (PubMed ID: 28317526)
1. Medical and Maintenance Treatments for Vitiligo.
Passeron T
Dermatol Clin; 2017 Apr; 35(2):163-170. PubMed ID: 28317526
[TBL] [Abstract][Full Text] [Related]
2. Vitiligo: an update on systemic treatments.
Searle T; Al-Niaimi F; Ali FR
Clin Exp Dermatol; 2021 Mar; 46(2):248-258. PubMed ID: 33350506
[TBL] [Abstract][Full Text] [Related]
3. [Systemic treatment of vitiligo : Balance and current developments].
Meurer M; Ceric-Dehdari P
Hautarzt; 2017 Nov; 68(11):876-884. PubMed ID: 29030646
[TBL] [Abstract][Full Text] [Related]
4. Vitiligo treatment update.
Daniel BS; Wittal R
Australas J Dermatol; 2015 May; 56(2):85-92. PubMed ID: 25495880
[TBL] [Abstract][Full Text] [Related]
5. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.
Liu LY; Strassner JP; Refat MA; Harris JE; King BA
J Am Acad Dermatol; 2017 Oct; 77(4):675-682.e1. PubMed ID: 28823882
[TBL] [Abstract][Full Text] [Related]
6. Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy.
Kim SR; Heaton H; Liu LY; King BA
JAMA Dermatol; 2018 Mar; 154(3):370-371. PubMed ID: 29387870
[No Abstract] [Full Text] [Related]
7. Topical cream delivers NB-UVB from sunlight for the treatment of vitiligo.
Wang X; McCoy J; Lotti T; Goren A
Expert Opin Pharmacother; 2014 Dec; 15(18):2623-7. PubMed ID: 25363734
[TBL] [Abstract][Full Text] [Related]
8. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
Li R; Qiao M; Wang X; Zhao X; Sun Q
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs).
Bae JM; Hong BY; Lee JH; Lee JH; Kim GM
J Am Acad Dermatol; 2016 May; 74(5):907-15. PubMed ID: 26785803
[TBL] [Abstract][Full Text] [Related]
10. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study.
Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y
Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595
[TBL] [Abstract][Full Text] [Related]
11. Different Advanced Therapeutic Approaches to Treat Vitiligo.
Sharma CK; Sharma M; Aggarwal B; Sharma V
J Environ Pathol Toxicol Oncol; 2015; 34(4):321-34. PubMed ID: 26756425
[TBL] [Abstract][Full Text] [Related]
12. Home phototherapy in vitiligo.
Mohammad TF; Silpa-Archa N; Griffith JL; Lim HW; Hamzavi IH
Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):241-252. PubMed ID: 28620923
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration.
Park JH; Park SW; Lee DY; Lee JH; Yang JM
Photodermatol Photoimmunol Photomed; 2013 Apr; 29(2):103-5. PubMed ID: 23458396
[TBL] [Abstract][Full Text] [Related]
14. Bridging Molecular Mechanism and Clinical Practice in Vitiligo Treatment: An Updated Review.
Ju HJ; Bae JM
Dermatology; 2024; 240(3):474-486. PubMed ID: 38417409
[TBL] [Abstract][Full Text] [Related]
15. Phototherapy for vitiligo, what's new?
Paro Vidolin A; Aurizi C; Leone G
G Ital Dermatol Venereol; 2017 Oct; 152(5):474-488. PubMed ID: 28906087
[TBL] [Abstract][Full Text] [Related]
16. Phototherapy: The vitiligo management pillar.
Esmat S; Mostafa W; Hegazy RA; Shalaby S; Sheth V; Youssef R; El-Mofty M
Clin Dermatol; 2016; 34(5):594-602. PubMed ID: 27638438
[TBL] [Abstract][Full Text] [Related]
17. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo.
McKesey J; Pandya AG
J Am Acad Dermatol; 2019 Aug; 81(2):646-648. PubMed ID: 31009664
[No Abstract] [Full Text] [Related]
19. Guidelines for the management of vitiligo: the European Dermatology Forum consensus.
Taieb A; Alomar A; Böhm M; Dell'anna ML; De Pase A; Eleftheriadou V; Ezzedine K; Gauthier Y; Gawkrodger DJ; Jouary T; Leone G; Moretti S; Nieuweboer-Krobotova L; Olsson MJ; Parsad D; Passeron T; Tanew A; van der Veen W; van Geel N; Whitton M; Wolkerstorfer A; Picardo M; ; ;
Br J Dermatol; 2013 Jan; 168(1):5-19. PubMed ID: 22860621
[TBL] [Abstract][Full Text] [Related]
20. Topical treatment and combination approaches for vitiligo: new insights, new developments.
Hossani-Madani AR; Halder RM
G Ital Dermatol Venereol; 2010 Feb; 145(1):57-78. PubMed ID: 20197746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
